SIGA — Put-Selling Research

by ThetaLoop Research
← Back to search
Last close: 2026-04-02
SIGA Technologies, Inc.
Healthcare · $5.24
1.0
/10
Avoid
How this score works →
Regime
Bearish
vs SMA200
SMA200 Distance
-25.9%
Below trend
Volatility
Normal
Average premiums
Momentum
Positive
Price direction
About SIGA Technologies, Inc.
SIGA manufactures TPOXX, the only FDA-approved smallpox antiviral, sold primarily to US government stockpiles under BARDA contracts. Single-product story with lumpy government procurement cycles. Occasional special dividends from excess cash. Low daily volume creates wide option spreads — binary event risk around contract renewals.
Biodefense Pharmaceuticals
Market Cap
$375M
P/E Ratio
16.4
Beta
1.06
52-Week Range Current: $5.24
$4.81 $9.62
Earnings
2026-05-07
32 days away
📊 View Full Research Track Record (All Wins AND Losses)
These free tools show market conditions and individual scores.
Our daily research goes deeper — covering option-specific data points, strike analysis, and risk metrics delivered via Telegram.
EXPLORE OUR RESEARCH — 14 DAYS FREE